ID   NCI-H1404
AC   CVCL_1468
SY   H1404; H-1404
DR   CLO; CLO_0007993
DR   ArrayExpress; E-MTAB-38
DR   ATCC; CRL-5819
DR   BioSample; SAMN03471744
DR   cancercelllines; CVCL_1468
DR   Cosmic; 877422
DR   Cosmic; 903591
DR   GDSC; 1330969
DR   IARC_TP53; 491
DR   IGRhCellID; NCIH1404
DR   KCLB; 91404
DR   LINCS_LDP; LCL-1912
DR   PharmacoDB; NCIH1404_1014_2019
DR   Progenetix; CVCL_1468
DR   Wikidata; Q54907803
RX   PubMed=1311061;
RX   PubMed=2386953;
RX   PubMed=8626706;
RX   PubMed=8806092;
RX   PubMed=11030152;
RX   PubMed=20215515;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln144Ter (c.430C>T); ClinVar=VCV000634688; Zygosity=Unspecified (PubMed=1311061).
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: KCLB; 91404; probable.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ATCC=CRL-5819
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 9,14
ST   D16S539: 12
ST   D18S51: 13
ST   D19S433: 13,14
ST   D21S11: 30,31.2
ST   D2S1338: 17
ST   D3S1358: 16,18
ST   D5S818: 12
ST   D7S820: 11,14
ST   D8S1179: 12,13
ST   FGA: 22,25
ST   Penta D: 9,11
ST   Penta E: 18
ST   TH01: 7,9.3
ST   TPOX: 9,11
ST   vWA: 19
DI   NCIt; C5650; Lung papillary adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 31
//
RX   PubMed=1311061;
RA   Mitsudomi T., Steinberg S.M., Nau M.M., Carbone D.P., D'Amico D.,
RA   Bodner S.M., Oie H.K., Linnoila R.I., Mulshine J.L., Minna J.D.,
RA   Gazdar A.F.;
RT   "p53 gene mutations in non-small-cell lung cancer cell lines and their
RT   correlation with the presence of ras mutations and clinical
RT   features.";
RL   Oncogene 7:171-180(1992).
//
RX   PubMed=2386953;
RA   Gazdar A.F., Linnoila R.I., Kurita Y., Oie H.K., Mulshine J.L.,
RA   Clark J.C., Whitsett J.A.;
RT   "Peripheral airway cell differentiation in human lung cancer cell
RT   lines.";
RL   Cancer Res. 50:5481-5487(1990).
//
RX   PubMed=8626706; DOI=10.1074/jbc.271.19.11477;
RA   Quinn K.A., Treston A.M., Unsworth E.J., Miller M.-J., Vos M.,
RA   Grimley C., Battey J., Mulshine J.L., Cuttitta F.;
RT   "Insulin-like growth factor expression in human cancer cell lines.";
RL   J. Biol. Chem. 271:11477-11483(1996).
//
RX   PubMed=8806092; DOI=10.1002/jcb.240630505;
RA   Phelps R.M., Johnson B.E., Ihde D.C., Gazdar A.F., Carbone D.P.,
RA   McClintock P.R., Linnoila R.I., Matthews M.J., Bunn P.A. Jr.,
RA   Carney D.N., Minna J.D., Mulshine J.L.;
RT   "NCI-Navy Medical Oncology Branch cell line data base.";
RL   J. Cell. Biochem. Suppl. 24:32-91(1996).
//
RX   PubMed=11030152; DOI=10.1038/sj.onc.1203815;
RA   Modi S., Kubo A., Oie H.K., Coxon A.B., Rehmatulla A., Kaye F.J.;
RT   "Protein expression of the RB-related gene family and SV40 large T
RT   antigen in mesothelioma and lung cancer.";
RL   Oncogene 19:4632-4639(2000).
//
RX   PubMed=20215515; DOI=10.1158/0008-5472.CAN-09-3458; PMCID=PMC2881662;
RA   Rothenberg S.M., Mohapatra G., Rivera M.N., Winokur D., Greninger P.,
RA   Nitta M., Sadow P.M., Sooriyakumar G., Brannigan B.W., Ulman M.J.,
RA   Perera R.M., Wang R., Tam A., Ma X.-J., Erlander M., Sgroi D.C.,
RA   Rocco J.W., Lingen M.W., Cohen E.E.W., Louis D.N., Settleman J.,
RA   Haber D.A.;
RT   "A genome-wide screen for microdeletions reveals disruption of
RT   polarity complex genes in diverse human cancers.";
RL   Cancer Res. 70:2158-2164(2010).
//